Connection

Yuko Palesch to Humans

Back to Details
This is a "connection" page, showing publications Yuko Palesch has written about Humans.
Yuko Palesch
Connection Strength
0.807
Humans
  1. Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage. Int J Stroke. 2019 04; 14(3):321-328.
    View in: PubMed
    Score: 0.024
  2. Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scale. J Biopharm Stat. 2019; 29(1):82-97.
    View in: PubMed
    Score: 0.023
  3. Comparison of multistate Markov modeling with contemporary outcomes in a reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. PLoS One. 2017; 12(10):e0187050.
    View in: PubMed
    Score: 0.022
  4. Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke. 2015 May; 46(5):1321-7.
    View in: PubMed
    Score: 0.019
  5. A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials. Stat Methods Med Res. 2017 Jun; 26(3):1078-1092.
    View in: PubMed
    Score: 0.018
  6. Continuous covariate imbalance and conditional power for clinical trial interim analyses. Contemp Clin Trials. 2014 May; 38(1):9-18.
    View in: PubMed
    Score: 0.017
  7. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke. 2013 Aug; 8(6):479-83.
    View in: PubMed
    Score: 0.017
  8. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013 06 20; 368(25):2432-3.
    View in: PubMed
    Score: 0.017
  9. Covariate imbalance and adjustment for logistic regression analysis of clinical trial data. J Biopharm Stat. 2013; 23(6):1383-402.
    View in: PubMed
    Score: 0.016
  10. Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trials. Pharm Stat. 2012 Jul-Aug; 11(4):310-7.
    View in: PubMed
    Score: 0.015
  11. Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocation. Stat Methods Med Res. 2015 Dec; 24(6):989-1002.
    View in: PubMed
    Score: 0.015
  12. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011 Dec; 15(3):559-76.
    View in: PubMed
    Score: 0.015
  13. Measuring continuous baseline covariate imbalances in clinical trial data. Stat Methods Med Res. 2015 Apr; 24(2):255-72.
    View in: PubMed
    Score: 0.015
  14. Quantitative comparison of randomization designs in sequential clinical trials based on treatment balance and allocation randomness. Pharm Stat. 2012 Jan-Feb; 11(1):39-48.
    View in: PubMed
    Score: 0.014
  15. Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization. Contemp Clin Trials. 2011 Mar; 32(2):250-9.
    View in: PubMed
    Score: 0.014
  16. A web-based medical safety reporting system for a large multicenter clinical trial: the ALIAS experience. Contemp Clin Trials. 2010 Nov; 31(6):536-43.
    View in: PubMed
    Score: 0.014
  17. Step-forward randomization in multicenter emergency treatment clinical trials. Acad Emerg Med. 2010 Jun; 17(6):659-65.
    View in: PubMed
    Score: 0.013
  18. An electronic regulatory document management system for a clinical trial network. Contemp Clin Trials. 2010 Jan; 31(1):27-33.
    View in: PubMed
    Score: 0.013
  19. Comments regarding the recent OAST article. Stroke. 2008 Jan; 39(1):e14; author reply e15.
    View in: PubMed
    Score: 0.011
  20. Power and sample size simulations for Randomized Play-the-Winner rules. Contemp Clin Trials. 2007 Jul; 28(4):487-99.
    View in: PubMed
    Score: 0.011
  21. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis. Stroke. 2006 Aug; 37(8):2107-14.
    View in: PubMed
    Score: 0.010
  22. Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005 Nov; 36(11):2410-4.
    View in: PubMed
    Score: 0.010
  23. An efficient multi-stage, single-arm Phase II futility design for ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep; 5 Suppl 1:55-6.
    View in: PubMed
    Score: 0.009
  24. A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. 2004 Jan-Feb; 13(1):53-63.
    View in: PubMed
    Score: 0.009
  25. Anxiety and anger among family practice residents: a South Carolina family practice research consortium study. Acad Med. 2003 Jan; 78(1):69-79.
    View in: PubMed
    Score: 0.008
  26. J-shape relation of blood pressure reduction and outcome in acute intracerebral hemorrhage: A pooled analysis of INTERACT2 and ATACH-II individual participant data. Int J Stroke. 2022 12; 17(10):1129-1136.
    View in: PubMed
    Score: 0.007
  27. Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review. Int J Stroke. 2022 06; 17(5):494-505.
    View in: PubMed
    Score: 0.007
  28. Regional Differences in the Response to Acute Blood Pressure Lowering After Cerebral Hemorrhage. Neurology. 2021 02 02; 96(5):e740-e751.
    View in: PubMed
    Score: 0.007
  29. Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Stroke. 2020 08; 51(8):2282-2286.
    View in: PubMed
    Score: 0.007
  30. Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 Trial. Cerebrovasc Dis. 2020; 49(1):26-31.
    View in: PubMed
    Score: 0.007
  31. National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke. Stroke. 2020 01; 51(1):282-290.
    View in: PubMed
    Score: 0.006
  32. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. JAMA Netw Open. 2019 09 04; 2(9):e1910769.
    View in: PubMed
    Score: 0.006
  33. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol. 2019 09; 18(9):857-864.
    View in: PubMed
    Score: 0.006
  34. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III. J Neurotrauma. 2019 10 15; 36(20):2863-2871.
    View in: PubMed
    Score: 0.006
  35. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. JAMA Neurol. 2019 07 01; 76(7):774-782.
    View in: PubMed
    Score: 0.006
  36. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke. Circulation. 2019 08 20; 140(8):658-664.
    View in: PubMed
    Score: 0.006
  37. The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury: Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical Trial. Crit Care Med. 2019 05; 47(5):623-631.
    View in: PubMed
    Score: 0.006
  38. Association between cigarette and alcohol consumption and Raynaud's phenomenon. J Clin Epidemiol. 1999 Apr; 52(4):321-8.
    View in: PubMed
    Score: 0.006
  39. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019 05; 18(5):428-438.
    View in: PubMed
    Score: 0.006
  40. Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage. Ann Neurol. 2019 01; 85(1):105-113.
    View in: PubMed
    Score: 0.006
  41. Symptoms of depression in residents: a South Carolina Family Practice Research Consortium study. Acad Med. 1998 Dec; 73(12):1305-10.
    View in: PubMed
    Score: 0.006
  42. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. Int J Stroke. 2019 02; 14(2):207-214.
    View in: PubMed
    Score: 0.006
  43. Blood Pressure-Attained Analysis of ATACH 2 Trial. Stroke. 2018 06; 49(6):1412-1418.
    View in: PubMed
    Score: 0.006
  44. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018 Jul 19; 379(3):215-225.
    View in: PubMed
    Score: 0.006
  45. The effectiveness of a magnetized water oral irrigator (Hydro Floss) on plaque, calculus and gingival health. J Clin Periodontol. 1998 Apr; 25(4):316-21.
    View in: PubMed
    Score: 0.006
  46. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018 02 22; 378(8):708-718.
    View in: PubMed
    Score: 0.006
  47. Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III. Prehosp Emerg Care. 2017 Sep-Oct; 21(5):539-544.
    View in: PubMed
    Score: 0.005
  48. Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. J Am Heart Assoc. 2017 May 08; 6(5).
    View in: PubMed
    Score: 0.005
  49. A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke. 2017 10; 12(8):896-905.
    View in: PubMed
    Score: 0.005
  50. Power of logrank test and Cox regression model in clinical trials with heterogeneous samples. Stat Med. 1997 Mar 15; 16(5):583-97.
    View in: PubMed
    Score: 0.005
  51. Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet. Stroke. 2017 03; 48(3):813-819.
    View in: PubMed
    Score: 0.005
  52. Intensive Blood-Pressure Lowering in Cerebral Hemorrhage. N Engl J Med. 2016 12 08; 375(23):e48.
    View in: PubMed
    Score: 0.005
  53. Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data. Stroke. 2016 12; 47(12):2931-2937.
    View in: PubMed
    Score: 0.005
  54. Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes. AJNR Am J Neuroradiol. 2017 Jan; 38(1):84-89.
    View in: PubMed
    Score: 0.005
  55. ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2. Stroke. 2016 09; 47(9):2355-9.
    View in: PubMed
    Score: 0.005
  56. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med. 2016 09 15; 375(11):1033-43.
    View in: PubMed
    Score: 0.005
  57. Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury. J Neurotrauma. 2017 01 01; 34(1):115-120.
    View in: PubMed
    Score: 0.005
  58. Effect of endovascular reperfusion in relation to site of arterial occlusion. Neurology. 2016 Feb 23; 86(8):762-70.
    View in: PubMed
    Score: 0.005
  59. The National Institutes of Health StrokeNet: A User's Guide. Stroke. 2016 Feb; 47(2):301-3.
    View in: PubMed
    Score: 0.005
  60. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Feb; 47(2):581-641.
    View in: PubMed
    Score: 0.005
  61. Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data. Stroke. 2015 Dec; 46(12):3416-22.
    View in: PubMed
    Score: 0.005
  62. Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial. PLoS One. 2015; 10(9):e0131390.
    View in: PubMed
    Score: 0.005
  63. Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial. AJNR Am J Neuroradiol. 2015 Nov; 36(11):2074-81.
    View in: PubMed
    Score: 0.005
  64. Imaging in StrokeNet: Realizing the Potential of Big Data. Stroke. 2015 Jul; 46(7):2000-6.
    View in: PubMed
    Score: 0.005
  65. Multi-modality neuro-monitoring: conventional clinical trial design. Neurocrit Care. 2015 Jun; 22(3):369-77.
    View in: PubMed
    Score: 0.005
  66. Assessing the impact of safety monitoring on the efficacy analysis in large Phase III group sequential trials with non-trivial safety event rate. J Biopharm Stat. 2016; 26(4):672-85.
    View in: PubMed
    Score: 0.005
  67. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. Stroke. 2015 Feb; 46(2):461-4.
    View in: PubMed
    Score: 0.005
  68. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014 Dec 25; 371(26):2457-66.
    View in: PubMed
    Score: 0.005
  69. Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions. J Neurointerv Surg. 2015 Nov; 7(11):795-802.
    View in: PubMed
    Score: 0.005
  70. Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke. 2014 Dec; 45(12):3606-11.
    View in: PubMed
    Score: 0.005
  71. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 2014 Oct; 273(1):202-10.
    View in: PubMed
    Score: 0.004
  72. Increased brain volume among good grade patients with intracerebral hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) study. Neurocrit Care. 2014 Jun; 20(3):470-5.
    View in: PubMed
    Score: 0.004
  73. Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014 Jun; 45(6):1791-8.
    View in: PubMed
    Score: 0.004
  74. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol. 2014 Jun; 13(6):567-74.
    View in: PubMed
    Score: 0.004
  75. Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke. 2014 May; 45(5):1408-14.
    View in: PubMed
    Score: 0.004
  76. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 2014 Mar; 45(3):759-64.
    View in: PubMed
    Score: 0.004
  77. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke. 2014 Feb; 45(2):444-9.
    View in: PubMed
    Score: 0.004
  78. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care. 2013 Oct; 19(2):257-66.
    View in: PubMed
    Score: 0.004
  79. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol. 2013 Nov; 12(11):1049-58.
    View in: PubMed
    Score: 0.004
  80. Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial. Int J Stroke. 2014 Feb; 9(2):226-31.
    View in: PubMed
    Score: 0.004
  81. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013 Mar 07; 368(10):893-903.
    View in: PubMed
    Score: 0.004
  82. Reliability of hematoma volume measurement at local sites in a multicenter acute intracerebral hemorrhage clinical trial. Stroke. 2013 Jan; 44(1):237-9.
    View in: PubMed
    Score: 0.004
  83. Systolic blood pressure reduction and risk of acute renal injury in patients with intracerebral hemorrhage. Am J Med. 2012 Jul; 125(7):718.e1-6.
    View in: PubMed
    Score: 0.004
  84. An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project. Ann Emerg Med. 2012 Oct; 60(4):451-7.
    View in: PubMed
    Score: 0.004
  85. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012 Feb 16; 366(7):591-600.
    View in: PubMed
    Score: 0.004
  86. Clinical trial design in the neurocritical care unit. Neurocrit Care. 2012 Feb; 16(1):6-19.
    View in: PubMed
    Score: 0.004
  87. Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial. J Biopharm Stat. 2012; 22(4):758-72.
    View in: PubMed
    Score: 0.004
  88. Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage. Neurocrit Care. 2011 Dec; 15(3):428-35.
    View in: PubMed
    Score: 0.004
  89. Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale. Parkinsonism Relat Disord. 2012 Mar; 18(3):230-3.
    View in: PubMed
    Score: 0.004
  90. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011 Nov; 42(11):3067-74.
    View in: PubMed
    Score: 0.004
  91. The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke. 2011 Jun; 42(6):1621-5.
    View in: PubMed
    Score: 0.004
  92. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke. 2011 Jan; 42(1):119-27.
    View in: PubMed
    Score: 0.003
  93. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 Jan; 42(1):227-76.
    View in: PubMed
    Score: 0.003
  94. Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke. 2010 Nov; 41(11):2581-6.
    View in: PubMed
    Score: 0.003
  95. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol. 2010 May; 67(5):570-6.
    View in: PubMed
    Score: 0.003
  96. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke. 2010 Apr; 41(4):732-8.
    View in: PubMed
    Score: 0.003
  97. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke. 2009 Nov; 40(11):3541-6.
    View in: PubMed
    Score: 0.003
  98. Using global statistical tests in long-term Parkinson's disease clinical trials. Mov Disord. 2009 Sep 15; 24(12):1732-9.
    View in: PubMed
    Score: 0.003
  99. The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat. 2009 Jul; 37(1):54-63.
    View in: PubMed
    Score: 0.003
  100. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008 Oct; 7(10):875-84.
    View in: PubMed
    Score: 0.003
  101. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008 Sep 18; 359(12):1238-51.
    View in: PubMed
    Score: 0.003
  102. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008 Sep 18; 359(12):1225-37.
    View in: PubMed
    Score: 0.003
  103. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke. 2008 May; 3(2):130-7.
    View in: PubMed
    Score: 0.003
  104. Design of the economic evaluation for the Interventional Management of Stroke (III) trial. Int J Stroke. 2008 May; 3(2):138-44.
    View in: PubMed
    Score: 0.003
  105. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol. 2008 Mar; 29(3):582-7.
    View in: PubMed
    Score: 0.003
  106. The albumin in acute stroke trial (ALIAS); design and methodology. Int J Stroke. 2007 Aug; 2(3):214-9.
    View in: PubMed
    Score: 0.003
  107. The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report. Biochem Soc Trans. 2006 Dec; 34(Pt 6):1323-6.
    View in: PubMed
    Score: 0.003
  108. Using the baseline CT scan to select acute stroke patients for IV-IA therapy. AJNR Am J Neuroradiol. 2006 Sep; 27(8):1612-6.
    View in: PubMed
    Score: 0.003
  109. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results. Stroke. 2006 Aug; 37(8):2100-6.
    View in: PubMed
    Score: 0.003
  110. Lessons from adult stroke trials. Pediatr Neurol. 2006 Jun; 34(6):446-9.
    View in: PubMed
    Score: 0.003
  111. Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 2006 Mar 14; 66(5):628-33.
    View in: PubMed
    Score: 0.002
  112. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery. 2005 Sep; 138(3):474-81.
    View in: PubMed
    Score: 0.002
  113. A responsive outcome for Parkinson's disease neuroprotection futility studies. Ann Neurol. 2005 Feb; 57(2):197-203.
    View in: PubMed
    Score: 0.002
  114. The role of radiotracer imaging in Parkinson disease. Neurology. 2005 Jan 25; 64(2):208-15.
    View in: PubMed
    Score: 0.002
  115. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clin Trials. 2005; 2(6):509-18.
    View in: PubMed
    Score: 0.002
  116. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004 Jun; 239(6):828-37; discussion 837-40.
    View in: PubMed
    Score: 0.002
  117. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA. 2004 Apr 14; 291(14):1713-9.
    View in: PubMed
    Score: 0.002
  118. Long-term follow-up of absence seizures. Neurology. 1983 Dec; 33(12):1590-5.
    View in: PubMed
    Score: 0.002
  119. Analysis of clustered matched-pair data. Stat Med. 2003 Aug 15; 22(15):2417-28.
    View in: PubMed
    Score: 0.002
  120. Analysis of clustered matched-pair data for a non-inferiority study design. Stat Med. 2003 Jan 30; 22(2):279-90.
    View in: PubMed
    Score: 0.002
  121. The nursing home population: different perspectives and implications for policy. Health Care Financ Rev. 1981 Dec; 3(2):15-23.
    View in: PubMed
    Score: 0.002
  122. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer. 2001 Jul 15; 93(2):162-71.
    View in: PubMed
    Score: 0.002
  123. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut. 2001 Jul; 49(1):29-34.
    View in: PubMed
    Score: 0.002
  124. Alcohol and mortality: the Honolulu Heart Study. Am J Med. 1980 Feb; 68(2):164-9.
    View in: PubMed
    Score: 0.002
  125. Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. J Clin Periodontol. 1999 Nov; 26(11):705-9.
    View in: PubMed
    Score: 0.002
  126. Contribution of interleukin 1beta and KM loci to alopecia areata. Hum Hered. 1999 Mar; 49(2):85-9.
    View in: PubMed
    Score: 0.002
  127. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology. 1998 Dec; 115(6):1518-24.
    View in: PubMed
    Score: 0.002
  128. Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis. J Clin Periodontol. 1998 Oct; 25(10):781-5.
    View in: PubMed
    Score: 0.001
  129. The body mass index-mortality relationship in white and African American women. Obes Res. 1998 Jul; 6(4):268-77.
    View in: PubMed
    Score: 0.001
  130. Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison. J Rheumatol. 1997 May; 24(5):879-89.
    View in: PubMed
    Score: 0.001
  131. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy. 1997 May; 29(4):252-7.
    View in: PubMed
    Score: 0.001
  132. The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesth Analg. 1996 Dec; 83(6):1256-61.
    View in: PubMed
    Score: 0.001
  133. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders. J Rheumatol. 1996 Dec; 23(12):2068-78.
    View in: PubMed
    Score: 0.001
  134. Physical and psychological health of family practice residents. Fam Med. 1995 Nov-Dec; 27(10):646-51.
    View in: PubMed
    Score: 0.001
  135. Stability of basal metabolic rate over selected days of the menstrual cycle. Obes Res. 1995 May; 3(3):301-2.
    View in: PubMed
    Score: 0.001
  136. Propranolol metabolism in normal subjects: association with sex steroid hormones. Clin Pharmacol Ther. 1994 Aug; 56(2):127-32.
    View in: PubMed
    Score: 0.001
  137. Sex differences in declining cohort death rates from heart disease. Am J Public Health. 1982 Feb; 72(2):161-6.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.